275 related articles for article (PubMed ID: 28321282)
1. Challenges with targeted viral load testing for medical inpatients at Queen Elizabeth Central Hospital in Blantyre, Malawi.
Craik A; Patel P; Patel P; Mallewa J; Malisita K; Bitilinyu-Bangoh J; van Oosterhout JJ; Kelly C
Malawi Med J; 2016 Dec; 28(4):179-181. PubMed ID: 28321282
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care viral load monitoring: outcomes from a decentralized HIV programme in Malawi.
Nicholas S; Poulet E; Wolters L; Wapling J; Rakesh A; Amoros I; Szumilin E; Gueguen M; Schramm B
J Int AIDS Soc; 2019 Aug; 22(8):e25387. PubMed ID: 31441242
[TBL] [Abstract][Full Text] [Related]
3. Dried blood spots for viral load monitoring in Malawi: feasible and effective.
Rutstein SE; Hosseinipour MC; Kamwendo D; Soko A; Mkandawire M; Biddle AK; Miller WC; Weinberger M; Wheeler SB; Sarr A; Gupta S; Chimbwandira F; Mwenda R; Kamiza S; Hoffman I; Mataya R
PLoS One; 2015; 10(4):e0124748. PubMed ID: 25898365
[TBL] [Abstract][Full Text] [Related]
4. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
[TBL] [Abstract][Full Text] [Related]
5. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
[TBL] [Abstract][Full Text] [Related]
6. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
[TBL] [Abstract][Full Text] [Related]
7. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings.
Rutstein SE; Golin CE; Wheeler SB; Kamwendo D; Hosseinipour MC; Weinberger M; Miller WC; Biddle AK; Soko A; Mkandawire M; Mwenda R; Sarr A; Gupta S; Mataya R
AIDS Care; 2016; 28(1):1-10. PubMed ID: 26278724
[TBL] [Abstract][Full Text] [Related]
8. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
[TBL] [Abstract][Full Text] [Related]
9. Implementation and operational feasibility of SAMBA I HIV-1 semi-quantitative viral load testing at the point-of-care in rural settings in Malawi and Uganda.
Gueguen M; Nicholas S; Poulet E; Schramm B; Szumilin E; Wolters L; Wapling J; Ajule E; Rakesh A; Mwenda R; Kiyaga C; Balkan S
Trop Med Int Health; 2021 Feb; 26(2):184-194. PubMed ID: 33159822
[TBL] [Abstract][Full Text] [Related]
10. Leveraging routine viral load testing to integrate diabetes screening among patients on antiretroviral therapy in Malawi.
Singano V; van Oosterhout JJ; Gondwe A; Nkhoma P; Cataldo F; Singogo E; Theu J; Ching'ani W; Hosseinpour MC; Amberbir A
Int Health; 2021 Feb; 13(2):135-142. PubMed ID: 32556207
[TBL] [Abstract][Full Text] [Related]
11. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM;
PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399
[TBL] [Abstract][Full Text] [Related]
12. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
[TBL] [Abstract][Full Text] [Related]
13. British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve.
Street E; Curtis H; Sabin CA; Monteiro EF; Johnson MA;
HIV Med; 2009 Jul; 10(6):337-42. PubMed ID: 19490183
[TBL] [Abstract][Full Text] [Related]
14. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
[TBL] [Abstract][Full Text] [Related]
15. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa.
Fox MP; Berhanu R; Steegen K; Firnhaber C; Ive P; Spencer D; Mashamaite S; Sheik S; Jonker I; Howell P; Long L; Evans D
Trop Med Int Health; 2016 Sep; 21(9):1131-7. PubMed ID: 27383454
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
[TBL] [Abstract][Full Text] [Related]
18. Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam.
Pham HV; Ishizaki A; Nguyen LV; Phan CT; Phung TT; Takemoto K; Pham AN; Bi X; Khu DT; Ichimura H
Int J STD AIDS; 2015 Oct; 26(11):821-30. PubMed ID: 25332224
[TBL] [Abstract][Full Text] [Related]
19. Routine viral load monitoring and enhanced adherence counselling at a public ART centre in Mumbai, India.
Laxmeshwar C; Acharya S; Das M; Keskar P; Pazare A; Ingole N; Mehta P; Gori P; Mansoor H; Kalon S; Singh P; Mathur T; Ferlazzo G; Isaakidis P
PLoS One; 2020; 15(5):e0232576. PubMed ID: 32369504
[TBL] [Abstract][Full Text] [Related]
20. Lack of effectiveness of adherence counselling in reversing virological failure among patients on long-term antiretroviral therapy in rural Uganda.
Birungi J; Cui Z; Okoboi S; Kapaata A; Munderi P; Mukajjanga C; Nanfuka M; Nyonyintono MS; Kim J; Zhu J; Kaleebu P; Moore DM
HIV Med; 2020 Jan; 21(1):21-29. PubMed ID: 31432614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
